Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6759270 | 0.86 | EPHX1 (0.35) | EPHX1 | |
| SCHEMBL16910357 | 0.79 | POLB (0.37) | — | |
| SCHEMBL3434135 | 0.75 | EPHX1 (0.39) | EPHX1 | |
| SCHEMBL5089575 | 0.72 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL10202771 | 0.72 | EPHX1 (0.37) | EPHX1 | |
| SCHEMBL10264236 | 0.72 | EPHX1 (0.37) | EPHX1 | |
| SCHEMBL3695518 | 0.72 | EPHX1 (0.37) | EPHX1 | |
| SCHEMBL16910356 | 0.71 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL2869376 | 0.69 | EPHX1 (0.34) | EPHX1 | |
| SCHEMBL15104778 | 0.68 | MEN1 (0.34) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6673947-B2 | ADDING A 3-ALKYLOXETANE METHANOL TO A FLUOROOLEFIN UNDER AN ALKALI CONDITION IN A SOLVENT AND AN ALKALI AQUEOUS SOLUTION IN PRESENCE OF (TETRABUTYLAMMONIUM CHLORIDE) A PHASE TRANSFER CATALYST | DAIKIN INDUSTRIES, INC. (JP) | 2004-01-06 | — | — | US | claimed |
| US-20030045733-A1 | Process for preparing 3-fluoroalkoxymethyl-3-alkyloxetanes | DAIKIN INDUSTRIES, LTD. (JP) | 2003-03-06 | — | — | US | claimed |
| EP-1270564-A1 | PROCESS FOR PREPARING 3-FLUOROALKOXYMETHYL-3-ALKYLOXETANES | Daikin Industries, Ltd. (JP) | 2003-01-02 | — | — | EP | claimed |
| EP-2902821-B1 | FILM MIRROR | FUJIFILM CORP (JP) | 2017-11-22 | — | — | EP | disclosed |
| US-9671599-B2 | Film mirror, and composite film for use in same | FUJIFILM CORPORATION (JP) | 2017-06-06 | — | — | US | disclosed |
| EP-2902821-A1 | FILM MIRROR, AND COMPOSITE FILM FOR USE IN SAME | FUJI-FILM Corporation (JP) | 2015-08-05 | — | — | EP | disclosed |
| US-20150205085-A1 | FILM MIRROR, AND COMPOSITE FILM FOR USE IN SAME | FUJIFILM CORPORATION (JP) | 2015-07-23 | — | — | US | disclosed |
| US-6777563-B2 | FLUOROALKOXY-OXETANES | DAIKIN INDUSTRIES, LTD. (JP) | 2004-08-17 | — | — | US | disclosed |
| US-20040097744-A1 | Process for preparing 3-fluoroalkoxymethyl-3-alkyloxetanes | DAIKIN INDUSTRIES, LTD. (JP) | 2004-05-20 | — | — | US | disclosed |
| US-6673947-B2 | ADDING A 3-ALKYLOXETANE METHANOL TO A FLUOROOLEFIN UNDER AN ALKALI CONDITION IN A SOLVENT AND AN ALKALI AQUEOUS SOLUTION IN PRESENCE OF (TETRABUTYLAMMONIUM CHLORIDE) A PHASE TRANSFER CATALYST | DAIKIN INDUSTRIES, INC. (JP) | 2004-01-06 | — | — | US | disclosed |
| US-20030045733-A1 | Process for preparing 3-fluoroalkoxymethyl-3-alkyloxetanes | DAIKIN INDUSTRIES, LTD. (JP) | 2003-03-06 | — | — | US | disclosed |
| EP-1270564-A1 | PROCESS FOR PREPARING 3-FLUOROALKOXYMETHYL-3-ALKYLOXETANES | Daikin Industries, Ltd. (JP) | 2003-01-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040097744-A1 | Process for preparing 3-fluoroalkoxymethyl-3-alkyloxetanes | CYP4F3, AFF4, CYP4F11 | EPHX1 1083/4885CNR2 2228/4885 |
| US-20030045733-A1 | Process for preparing 3-fluoroalkoxymethyl-3-alkyloxetanes | CYP4F3, AFF4, CYP4F11 | EPHX1 1083/4885CNR2 2228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.